4.5 Review

Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease

Maiko T. Uemura et al.

Summary: Limbic-predominant age-related TDP-43 encephalopathy (LATE) is characterized by the accumulation of TAR-DNA-binding protein 43 (TDP-43) aggregates in older adults and coexists with Lewy body disease (LBD) and Alzheimer's disease (AD). Pathological and genetic characteristics of LATE in LBD (LATE-LBD) differ from LATE-AD, with associations to patient profiles and cognitive impairment. The distribution of LATE neuropathological changes and genetic risk factors also vary between LATE-LBD and LATE-AD.

ACTA NEUROPATHOLOGICA (2022)

Article Neurosciences

Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities

Robin de Flores et al.

Summary: This study reveals the relationship between the medial temporal lobe and the anterior-temporal and posterior-medial networks, and explores the vulnerability of these networks to proteinopathies in Alzheimer's disease. The results show that the atrophy of distinct subregions in the medial temporal lobe propagates differently within the anterior-temporal and posterior-medial networks. Additionally, these networks are differentially associated with relative tau and amyloid burden.

JOURNAL OF NEUROSCIENCE (2022)

Article Multidisciplinary Sciences

Structure of pathological TDP-43 filaments from ALS with FTLD

Diana Arseni et al.

Summary: Abnormal aggregation of TDP-43 is a defining pathological hallmark in ALS and FTLD, as well as in other diseases. Cryo-electron microscopy revealed an amyloid-like filament structure comprising a single protofilament with a unique double-spiral-shaped fold in aggregated TDP-43, different from in vitro-formed filaments. The presence of glycine and neutral polar residues facilitates numerous turns and restricts beta-strand length, resulting in an absence of beta-sheet stacking and unique ligand-binding site possibilities. These findings enhance our understanding of ALS and FTLD molecular pathogenesis and inform the development of diagnostic and therapeutic agents targeting aggregated TDP-43.

NATURE (2022)

Article Clinical Neurology

Limbic-Predominant Age-Related TDP-43 Encephalopathy Medical and Pathologic Factors Associated With Comorbid Hippocampal Sclerosis

Kathryn M. Gauthreaux et al.

Summary: Limbic-predominant age-related Tar DNA binding protein 43 (TDP-43) encephalopathy neuropathologic change (LATE-NC) is strongly associated with cognitive impairment. This study found that LATE-NC patients with hippocampal sclerosis (HS) pathology may have worse cognitive status and more severe impairments in memory and orientation. Additionally, the presence of comorbid HS pathology is associated with more widespread TDP-43 proteinopathy and more severe non-beta-amyloid vessel wall pathologies.

NEUROLOGY (2022)

Article Neuroimaging

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration

Marina Buciuc et al.

Summary: The study found differences and similarities in longitudinal brain volume loss between FTLD-TDP and non-FTLD TDP-43, with faster atrophy rates in certain brain regions for FTLD-TDP and faster hippocampal atrophy rates in AD-TDP type-a.

NEUROIMAGE-CLINICAL (2022)

Article Neurosciences

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition

Sheelakumari Raghavan et al.

Summary: Multi-compartment modelling of white matter microstructure using NODDI can provide valuable information for distinguishing the underlying substrate for cognitive impairment in older adults. The study found distinct NODDI readouts of white matter damage associated with different diseases, which are informative for identifying cognitive impairment.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Biochemistry & Molecular Biology

Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases

Andrew Chang et al.

Summary: This study demonstrates the presence of amyloid fibrils composed of TMEM106B in various neurodegenerative diseases, suggesting a potential shared fibrillization pathway.
Article Neurosciences

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration

Alba Cervantes Gonzalez et al.

Summary: The study found an association between synaptic proteins and pathological burden and cognitive performance in frontotemporal lobar degeneration (FTLD) patients. These synaptic panels have the potential to differentiate FTLD neuropathologic subtypes and serve as surrogate markers for cognitive performance in future clinical trials.

MOLECULAR NEURODEGENERATION (2022)

Article Multidisciplinary Sciences

Age-dependent formation of TMEM106B amyloid filaments in human brains

Manuel Schweighauser et al.

Summary: The study found that TMEM106B protein forms amyloid filaments in the brains of patients with various neurodegenerative diseases. The structures of TMEM106B filaments differ in different brain regions and do not show clear associations with specific diseases. The presence of TMEM106B filaments in the brains of older individuals suggests an age-dependent formation pattern, which is not observed in younger individuals with normal neurology.

NATURE (2022)

Article Multidisciplinary Sciences

Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43

Yi Xiao Jiang et al.

Summary: This study found that amyloid fibrils in FTLD-TDP patients are formed by TMEM106B protein rather than TDP-43 protein. In addition, abundant non-fibrillar aggregated TDP-43 protein was observed.

NATURE (2022)

Review Clinical Neurology

Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

Teresa Gomez-Isla et al.

Summary: Some individuals can accumulate high levels of Alzheimer's disease neuropathological changes without showing symptoms, which has implications for risk prediction and the development of therapeutic interventions.

NATURE REVIEWS NEUROLOGY (2022)

Article Multidisciplinary Sciences

Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease

Michael Tran Duong et al.

Summary: Through machine learning, heterogeneity in F-18-flortaucipir and F-18-fluorodeoxyglucose PET scans was assessed in 289 symptomatic AD patients, revealing distinct imaging signatures with pathobiological and prognostic implications for AD.

NATURE COMMUNICATIONS (2022)

Article Clinical Neurology

Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts

Peter T. Nelson et al.

Summary: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) and Alzheimer's disease neuropathologic change (ADNC) are both associated with cognitive impairment in aging populations, with LATE-NC being present in approximately 40% of participants and more commonly in cases with poorer cognitive abilities.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

Tau-Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease

Sandhitsu R. Das et al.

Summary: The study aimed to investigate the impact of Tau neurofibrillary tangles on neurodegeneration, and identified age and burden of white matter hyperintensity lesions as related modulatory factors. Data analysis showed that grouping individuals based on the relationship between Tau neurofibrillary tangles and neurodegeneration may help identify potential contributors to neurodegeneration.

ANNALS OF NEUROLOGY (2021)

Article Neurosciences

Blood TDP-43 Combined with Demographics Information Predicts Dementia Occurrence in Community Non-Dementia Elderly

Lin Sun et al.

Summary: In this study, it was found that blood TDP-43 levels were higher in subjects progressing from NC/MCI to dementia compared to stable NC/MCI group. A combination of baseline blood TDP-43 levels with demographics could predict dementia occurrence, while baseline blood levels of NfL were negatively associated with cognitive function at 7-year follow-up. Additionally, there was no relationship between CSF and blood levels of TDP-43, and the levels of TDP-43 in CSF were positively associated with the age of patients, especially in AD group.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Clinical Neurology

TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis

Leon Beyer et al.

Summary: The study shows that measuring the misfolding of TDP-43 in the cerebrospinal fluid of ALS patients using immuno-infrared sensor technology has the potential to serve as a biomarker for ALS. The technology can accurately distinguish ALS patients from other control groups.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Clinical Neurology

Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change and microvascular pathologies in community-dwelling older persons

Sonal Agrawal et al.

Summary: The study found that LATE-NC is commonly associated with microvascular pathologies, particularly posterior watershed arteriolosclerosis. This suggests that small vessel disease pathology may play a role in the development of LATE-NC in the aging brain.

BRAIN PATHOLOGY (2021)

Review Neurosciences

TDP-43 Pathology in Alzheimer's Disease

Axel Meneses et al.

Summary: TDP-43, a protein encoded by the TARDBP gene, plays a crucial role in various neurodegenerative diseases such as ALS, FTLD, and AD. Its pathology is associated with cognitive impairment severity and genetic risk factors, such as APOE4, in AD.

MOLECULAR NEURODEGENERATION (2021)

Article Neurosciences

Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology

Sadhana Ravikumar et al.

Summary: The study revealed a close association between tau neurofibrillary tangle pathology and neurodegeneration in the medial temporal lobe. Significant correlations were found between regional thickness in the entorhinal cortex and stratum radiatum lacunosum moleculare and tau pathology severity, especially in cases with low levels of TDP-43 pathology.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Neurosciences

The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons

Sonal Agrawal et al.

Summary: LBs and LATE-NC are common in older individuals and linked to cognitive impairment. The combination of LBs and LATE-NC may affect cognition and Alzheimer's dementia in community-dwelling participants. Neocortical-type LBs are associated with LATE-NC, particularly in younger old individuals and women, and have separate and additive effects on cognitive function and odds of Alzheimer's dementia.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Clinical Neurology

Distinct brain-derived TDP-43 strains from FTLD-TDP subtypes induce diverse morphological TDP-43 aggregates and spreading patterns in vitro and in vivo

Silvia Porta et al.

Summary: This study demonstrates the presence of distinct TDP-43 strains in the brains of different FTLD-TDP subtypes with specific seeding and spreading properties in experimental animal models.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Review Geriatrics & Gerontology

Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy

Michael Tran Duong et al.

Summary: VCID is a common cause of cognitive decline, primarily caused by atherosclerosis leading to cerebrovascular disease and eventually neurodegeneration. Risk factors including hypercholesterolemia and hypertension promote atherosclerosis and carotid artery stenosis, disrupting cerebral blood flow and triggering ischemic strokes and VCID. The role of APOE, particularly APOE4, in lipid metabolism and chronic inflammation contributes to the pathogenesis of VCID.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Genetics & Heredity

A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease

Douglas P. Wightman et al.

Summary: This study identified seven new genetic loci associated with Alzheimer's disease through a genome-wide association study, implicating microglia and immune cells in late-onset disease. The research highlights the relevance of microglia, immune cells, and protein catabolism to late-onset Alzheimer's disease, while prioritizing previously unidentified genes for further investigation. The results are expected to contribute to larger meta-analyses to uncover additional genetic variants affecting Alzheimer's pathology.

NATURE GENETICS (2021)

Editorial Material Clinical Neurology

What Is the Role of Stathmin-2 in Axonal Biology and Degeneration?

Eduardo Benarroch

Summary: Stathmin-2, regulated by nuclear TDP-43, plays a crucial role in axonal development and repair. Reduced nuclear TDP-43 function leads to improper splicing of the gene encoding STMN2, resulting in the production of a truncated protein which is linked to axonal degeneration.

NEUROLOGY (2021)

Article Clinical Neurology

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis

Yuting Ren et al.

Summary: The levels of plasma TDP-43 and pTDP-43 were significantly higher in ALS patients compared to healthy controls, with plasma TDP-43 showing high sensitivity and specificity in differentiating between the two groups and indicating disease progression.

FRONTIERS IN NEUROLOGY (2021)

Article Neurosciences

Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions

L. E. M. Wisse et al.

Summary: The study investigated the associations between neurodegenerative pathologies and the thickness of medial temporal lobe subregions using post-mortem MRI. The findings revealed significant correlations of TDP-43 with thickness in all subregions, and tau with specific regions like BA35 and SRLM. Strong associations of tau with certain regions were observed in cases without amyloid-beta, indicating a potential role of Primary Age-Related Tauopathy in neurodegeneration.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Neurosciences

Analysis of genes (TMEM106B, GRN, ABCC9, KCNMB2, and APOE) implicated in risk for LATE-NC and hippocampal sclerosis provides pathogenetic insights: a retrospective genetic association study

Adam J. Dugan et al.

Summary: Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-NC) is one of the most common subtypes of TDP-43 proteinopathy, often co-occurring with hippocampal sclerosis (HS) pathology, and showing associations with specific genetic variants. Through analyzing the genetic associations with HS, LATE-NC, and Alzheimer's pathologies, significant gene-based associations were found, offering new insights into the differential effects of risk alleles on LATE-NC and HS.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Clinical Neurology

The development and convergence of co-pathologies in Alzheimer's disease

John L. Robinson et al.

Summary: This study found that CAA, LATE-NC, and Lewy bodies are common pathologies in Alzheimer's disease that worsen in severity as the disease progresses. Age was associated with all pathologies, while the APOE epsilon 4 gene was specifically linked to CAA. In individuals with dementia, age was linked to LATE-NC, while Lewy bodies were more common in younger patients.
Review Clinical Neurology

TDP-43 proteinopathies: a new wave of neurodegenerative diseases

Eva Maria Johanna de Boer et al.

Summary: TDP-43 is a crucial protein involved in the pathogenesis of various neurodegenerative diseases, including ALS and FTLD. Understanding the molecular pathways through which TDP-43 mediates neurodegeneration is essential for the development of effective therapies.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Article Clinical Neurology

Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations

Lilah M. Besser et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)

Article Clinical Neurology

Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease

Robin de Flores et al.

ALZHEIMERS & DEMENTIA (2020)

Article Multidisciplinary Sciences

TDP-43 dysfunction restricts dendritic complexity by inhibiting CREB activation and altering gene expression

Josiah J. Herzog et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Clinical Neurology

Hippocampal sclerosis, TDP-43, and the duration of the symptoms of dementia of AD patients

Oscar L. Lopez et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

Article Clinical Neurology

Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy

Marina Buciuc et al.

NEUROLOGY (2020)

Review Biochemistry & Molecular Biology

The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies

Myungjin Jo et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Article Geriatrics & Gerontology

TDP-43 Is Elevated in Plasma Neuronal-Derived Exosomes of Patients With Alzheimer's Disease

Nan Zhang et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Medicine, Research & Experimental

Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia

Mercedes Prudencio et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Neurosciences

RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43

Jacob R. Mann et al.

NEURON (2019)

Review Chemistry, Medicinal

Current radiotracers to image neurodegenerative diseases

Solveig Tiepolt et al.

EJNMMI RADIOPHARMACY AND CHEMISTRY (2019)

Review Clinical Neurology

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

Clifford R. Jack et al.

ALZHEIMERS & DEMENTIA (2018)

Article Neurosciences

TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease

Sukriti Nag et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)

Article Public, Environmental & Occupational Health

Prevalence of Amyotrophic Lateral Sclerosis - United States, 2015

Paul Mehta et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Medicine, Research & Experimental

Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies

Lin Guo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)

Review Biochemistry & Molecular Biology

Ageing as a risk factor for ALS/FTD

Teresa Niccoli et al.

HUMAN MOLECULAR GENETICS (2017)

Article Genetics & Heredity

A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression

Michael D. Gallagher et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2017)

Review Clinical Neurology

ALS/FTLD: experimental models and reality

Rachel H. Tan et al.

ACTA NEUROPATHOLOGICA (2017)

Article Clinical Neurology

TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia

Bryan D. James et al.

Review Neurosciences

TDP-43 as a possible biomarker for frontotemporal lobar degeneration: a systematic review of existing antibodies

Joery Goossens et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2015)

Article Clinical Neurology

Staging TDP-43 pathology in Alzheimer's disease

Keith A. Josephs et al.

ACTA NEUROPATHOLOGICA (2014)

Article Clinical Neurology

ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology

Peter T. Nelson et al.

ACTA NEUROPATHOLOGICA (2014)

Article Biochemistry & Molecular Biology

The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function

Owen A. Brady et al.

HUMAN MOLECULAR GENETICS (2013)

Article Clinical Neurology

TDP-43 Pathology, Cognitive Decline, and Dementia in Old Age

Robert S. Wilson et al.

JAMA NEUROLOGY (2013)

Article Psychiatry

The epidemiology of frontotemporal dementia

Chiadi U. Onyike et al.

INTERNATIONAL REVIEW OF PSYCHIATRY (2013)

Review Biochemistry & Molecular Biology

TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies

Todd J. Cohen et al.

TRENDS IN MOLECULAR MEDICINE (2011)

Article Genetics & Heredity

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions

Vivianna M. Van Deerlin et al.

NATURE GENETICS (2010)

Article Clinical Neurology

Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly

Dennis W. Dickson et al.

NEURODEGENERATIVE DISEASES (2010)

Article Multidisciplinary Sciences

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease

David A. Wolk et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Clinical Neurology

Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis

Takashi Kasai et al.

ACTA NEUROPATHOLOGICA (2009)

Article Biochemistry & Molecular Biology

TDP-43 is recruited to stress granules in conditions of oxidative insult

Claudia Colombrita et al.

JOURNAL OF NEUROCHEMISTRY (2009)

Article Clinical Neurology

Pallidonigral TDP-43 pathology in Perry syndrome

Christian Wider et al.

PARKINSONISM & RELATED DISORDERS (2009)

Article Clinical Neurology

The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia

Ian R. A. Mackenzie et al.

CURRENT OPINION IN NEUROLOGY (2008)

Article Clinical Neurology

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases

Hanae Nakashima-Yasuda et al.

ACTA NEUROPATHOLOGICA (2007)

Article Clinical Neurology

TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease

Catalina Amador-Ortiz et al.

ANNALS OF NEUROLOGY (2007)

Article Biochemistry & Molecular Biology

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Tetsuaki Arai et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Multidisciplinary Sciences

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Manuela Neumann et al.

SCIENCE (2006)